| Literature DB >> 31547129 |
Jihion Yu1, Jun-Young Park2, Doo-Hwan Kim3, Sungwon Kim4, Jai-Hyun Hwang5, Hyungseok Seo6, Young-Kug Kim7.
Abstract
Robot-assisted laparoscopic prostatectomy (RALP) is a minimally invasive technique for the treatment of prostate cancer. RALP requires the patient to be placed in the steep Trendelenburg position, along with pneumoperitoneum, which may increase the risk of postoperative pulmonary complications (PPCs). This large single-center retrospective study evaluated the incidence and risk factors of PPCs in 2208 patients who underwent RALP between 2014 and 2017. Patients were divided into those with (PPC group) and without (non-PPC group) PPCs. Postoperative outcomes were evaluated, and univariate and multivariate logistic regression analyses were performed to assess risk factors of PPCs. PPCs occurred in 682 patients (30.9%). Risk factors of PPCs included age (odds ratio [OR], 1.023; p = 0.001), body mass index (OR, 1.061; p = 0.001), hypoalbuminemia (OR, 1.653; p = 0.008), and positive end-expiratory pressure (PEEP) application (OR, 0.283; p < 0.001). The incidence of postoperative complications, rate of intensive care unit (ICU) admission, and duration of ICU stay were significantly greater in the PPC group than in the non-PPC group. In conclusion, the incidence of PPCs in patients who underwent RALP under pneumoperitoneum in the steep Trendelenburg position was 30.9%. Factors associated with PPCs included older age, higher body mass index, hypoalbuminemia, and lack of PEEP.Entities:
Keywords: incidence; postoperative pulmonary complications; risk factors; robot-assisted laparoscopic prostatectomy
Year: 2019 PMID: 31547129 PMCID: PMC6833011 DOI: 10.3390/jcm8101509
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Demographic and clinical characteristics.
| Variables | All Patients | PPC Group | Non-PPC Group | |
|---|---|---|---|---|
| Age (years) | 65.2 ± 7.1 | 66.0 ± 6.8 | 64.9 ± 7.2 | 0.001 |
| Body mass index (kg/m2) | 25.0 ± 2.7 | 25.2 ± 2.7 | 24.9 ± 2.7 | 0.006 |
| ASA physical status | 0.150 | |||
| ≤II | 1841 (83.4) | 557 (81.7) | 1284 (84.1) | |
| III | 367 (16.6) | 125 (18.3) | 242 (15.9) | |
| Hypertension | 968 (43.8) | 314 (46.0) | 654 (42.9) | 0.164 |
| Diabetes mellitus | 360 (16.3) | 117 (17.2) | 243 (15.9) | 0.469 |
| Coronary artery disease | 165 (7.5) | 52 (7.6) | 113 (7.4) | 0.856 |
| Chronic kidney disease | 14 (0.6) | 4 (0.6) | 10 (0.7) | 0.851 |
| Cerebrovascular accident | 106 (4.8) | 33 (4.8) | 73 (4.8) | 0.955 |
| Chronic obstructive pulmonary disease | 60 (2.7) | 21 (3.1) | 39 (2.6) | 0.485 |
| Smoking history | 0.777 | |||
| Non-smoker | 1039 (47.1) | 328 (48.1) | 711 (46.6) | |
| Current-smoker | 196 (8.9) | 61 (8.9) | 135 (8.8) | |
| Ex-smoker | 973 (44.1) | 293 (43.0) | 680 (44.6) | |
| Preoperative laboratory tests | ||||
| White blood cells (103/µL) | 6.3 ± 1.7 | 6.2 ± 1.7 | 6.3 ± 1.8 | 0.509 |
| Hemoglobin (g/dL) | 14.4 ± 1.2 | 14.4 ± 1.2 | 14.5 ± 1.2 | 0.251 |
| Platelets (103/µL) | 220.9 ± 54.7 | 217.4 ± 51.6 | 222.5 ± 56.0 | 0.042 |
| Albumin (g/dL) | 3.92 ± 0.31 | 3.88 ± 0.31 | 3.93 ± 0.31 | <0.001 |
| Hypoalbuminemia | 133 (6.0) | 54 (7.9) | 79 (5.2) | 0.012 |
| Uric acid (mg/dL) | 5.40 ± 1.28 | 5.42 ± 1.28 | 5.38 ± 1.28 | 0.484 |
| Creatinine (mg/dL) | 0.94 ± 0.24 | 0.93 ± 0.21 | 0.94 ± 0.25 | 0.390 |
Continuous variables are presented as mean ± standard deviation and categorical variables as number (percent). * For comparisons between the PPC and non-PPC groups. PPC, postoperative pulmonary complication; ASA, American Society of Anesthesiologists.
Intraoperative data.
| Variables | All Patients | PPC Group | Non-PPC Group | |
|---|---|---|---|---|
| Duration of anesthesia (min) | 204.7 ± 33.4 | 204.8 ± 34.1 | 204.7 ± 33.1 | 0.905 |
| Duration of operation (min) | 158.3 ± 39.9 | 158.9 ± 32.7 | 158.1 ± 42.8 | 0.645 |
| Anesthetic agent | 0.006 | |||
| Sevoflurane | 1396 (63.2) | 398 (58.4) | 998 (65.4) | |
| Desflurane | 616 (27.9) | 213 (31.2) | 403 (26.4) | |
| Propofol | 196 (8.9) | 71 (10.4) | 125 (8.2) | |
| Positive end-expiratory pressure | 384 (17.4) | 51 (7.5) | 333 (21.8) | <0.001 |
| Crystalloid administered (mL/kg) | 21.7 ± 8.3 | 21.5 ± 9.6 | 21.8 ± 7.6 | 0.443 |
| Colloid administered (mL/kg) | 0.9 ± 2.4 | 1.1 ± 2.5 | 0.8 ± 2.4 | 0.024 |
| Red blood cell transfusion | 8 (0.4) | 4 (0.6) | 4 (0.3) | 0.241 |
Continuous variables are presented as mean ± standard deviation and categorical variables as number (percent). * For comparisons between the PPC and non-PPC groups. PPC, postoperative pulmonary complication.
Univariate and multivariate logistic regression analyses of factors predictive of postoperative pulmonary complications.
| Variables | Univariate Analysis | Multivariate Analysis | ||
|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | |||
| Age | 1.023 (1.009–1.036) | 0.001 | 1.023 (1.010–1.037) | 0.001 |
| Body mass index | 1.048 (1.013–1.083) | 0.007 | 1.061 (1.024–1.098) | 0.001 |
| ASA physical status | 1.191 (0.939–1.510) | 0.150 | ||
| Chronic obstructive pulmonary disease | 1.211 (0.707–2.075) | 0.485 | ||
| Smoking history | ||||
| Non-smoker | 1.000 | |||
| Current-smoker | 0.979 (0.705–1.362) | 0.902 | ||
| Ex-smoker | 0.934 (0.773–1.129) | 0.480 | ||
| Hemoglobin | 0.957 (0.888–1.032) | 0.251 | ||
| Platelet | 0.998 (0.996–1.000) | 0.042 | 0.999 (0.997–1.001) | 0.224 |
| Hypoalbuminemia | 1.575 (1.100–2.254) | 0.013 | 1.653 (1.139–2.400) | 0.008 |
| Duration of operation | 1.001 (0.998–1.003) | 0.645 | ||
| Anesthetic agent | ||||
| Sevoflurane | 1.000 | |||
| Desflurane | 1.325 (1.082–1.623) | 0.006 | 0.987 (0.790–1.235) | 0.912 |
| Propofol | 1.424 (1.041–1.949) | 0.027 | 1.140 (0.827–1.572) | 0.424 |
| Positive end-expiratory pressure | 0.290 (0.212–0.395) | <0.001 | 0.283 (0.207–0.387) | <0.001 |
| Crystalloid administered | 0.996 (0.984–1.007) | 0.443 | ||
| Colloid administered | 1.042 (1.005–1.081) | 0.024 | 1.000 (1.000–1.001) | 0.138 |
| Red blood cell transfusion | 2.245 (0.560–9.002) | 0.254 | ||
OR, odds ratio; CI, confidence interval; ASA, American Society of Anesthesiologists.
Postoperative outcomes.
| Variables | PPC Group | Non-PPC Group | |
|---|---|---|---|
| Clavien–Dindo classification system | <0.001 | ||
| I | 35 (5.1) | 73 (4.8) | |
| II | 26 (3.8) | 6 (0.4) | |
| IIIa | 2 (0.3) | 1 (0.1) | |
| IIIb | 3 (0.4) | 4 (0.3) | |
| IVa | 2 (0.3) | 6 (0.4) | |
| IVb | 0 (0.0) | 0 (0.0) | |
| V | 0 (0.0) | 0 (0.0) | |
| Duration of hospital stay (days) | 6.47 ± 2.25 | 6.45 ± 4.18 | 0.910 |
| Rate of ICU admission | 19 (2.8) | 18 (1.2) | 0.007 |
| Duration of ICU stay (days) | 0.06 ± 0.34 | 0.02 ± 0.22 | 0.005 |
Continuous variables are presented as mean ± standard deviation and categorical variables as number (percent). * For comparisons between the PPC and non-PPC groups. PPC, postoperative pulmonary complication; ICU, intensive care unit.